skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pharma Intelligence Logo
Search Icon Pharma Report StoreProduct loginProductLogin
Global Search Configuration

Pharma R&D Annual Review 2021

Our world was disrupted at warp speed during 2020. Are you ready to gain a deeper understanding of the year that changed our perceptions of possible? Penned for the 29th time by Ian Lloyd – Senior Director, Pharmaprojects, the Pharma R&D Annual Review 2021 is ready to transport you into the pharma R&D universe.

We will be travelling deep into the pipeline by company, therapeutic area, disease, target, and drug type – using data from Informa Pharma Intelligence’s Pharmaprojects, part of Informa’s Citeline family of intelligence solutions, which has been tracking global drug development since 1980. (And if you hadn’t guessed already, Ian has drawn inspiration from the realm of science fiction to give this year’s whitepaper an extra dimension.) 

Pharma R&D Annual Review 2021
Download infographic Download whitepaper

Pharma R&D Annual Review 2021 Supplement: New Active Substances Launched During 2020

New Active Substances (NAS) Launched During 2020 is an information-rich supplement that follows on from the Pharma R&D Annual Review 2021. This year’s supplement provides detailed statistics, year-on-year trends and insightful analysis on the year’s NAS launches, making this a must-read for the pharma industry. 

New Active Substances Launched During 2020: Infographic

Our Infographic provides a snapshot of critical insights from the New Active Substances (NAS) Launched During 2020 supplement. Download your copy to find out how new drug delivery was impacted by the alien Coronavirus invasion.  
NAS Infographic
Download Infographic

New Active Substances Launched During 2020: Whitepaper

Ian Lloyd – Senior Director, Pharmaprojects & Data Integration, shares his expert insights on the new drugs approved for use in patients that made it to market during the year, using data from Pharmaprojects, part of Informa’s Citeline stable of intelligence solutions.
PharmaRD__NAS Whitepaper
Download Whitepaper

Watch Ian discuss the Pharma R&D Annual Review 2021.

 

 

 



Check out our Intergalactic Pharma R&D Annual Review 2021 Spotify Playlist

Make sure you listen to our special Spotify playlist while you read. We hope you enjoy this tongue-in-cheek collection of songs, specially curated as the perfect accompaniment to the Pharma R&D Annual Review 2021.

Listen to playlist.

 

 

 


 

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact Sales

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Contact Customer Services

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now:

Shop now